Epistaxis in hospitalized patients with COVID-19.
Valeria Dell'EraRiccardo DosdeganiPaolo Aluffi VallettiMassimiliano GarzaroPublished in: The Journal of international medical research (2020)
Spontaneous epistaxis in patients with COVID-19 can represent a clinical challenge with respect to both the risk of contamination and the treatment options. We herein present the data of 30 patients with COVID-19 who developed spontaneous epistaxis while hospitalized at Eastern Piedmont Hospital during March and April 2020. All patients received low-molecular-weight heparin during their hospital stay and required supplementary oxygen therapy either by a nasal cannula or continuous positive airway pressure. Both conditions can represent risk factors for developing epistaxis. Prevention of crust formation in patients with rhinitis using a nasal lubricant should be recommended. If any treatment is required, appropriate self-protection is mandatory.
Keyphrases
- positive airway pressure
- obstructive sleep apnea
- end stage renal disease
- healthcare
- sleep apnea
- ejection fraction
- chronic kidney disease
- prognostic factors
- acute care
- adverse drug
- stem cells
- electronic health record
- emergency department
- growth factor
- extracorporeal membrane oxygenation
- machine learning
- patient reported outcomes
- mesenchymal stem cells
- respiratory failure
- acute respiratory distress syndrome
- artificial intelligence
- data analysis